Seroquel Use Expanded Despite Side Effects and Lawsuits
Although there are currently thousands of Seroquel lawsuits alleging that AstraZeneca failed to adequately warn about serious side effects like diabetes and pancreatitis, the FDA recently announced that a new form of Seroquel, known as Seroquel XR, will be approved for treatment of bipolar disorder.
Seroquel (quetiapine fumarate) is an atypical anti-psychotic medication that was originally approved in 1997 as a twice daily treatment for schizophrenia.
Seroquel XR is an extended release version, which is approved for treatment of mania, depressive and mixed episodes in bipolar disorder, as well as schizophrenia. It will be used in the maintenance treatment of bipolar disorder along with divalproex or lithium.
For years, AstraZeneca has been accused for years of aggressively promoting Seroquel for previously non-approved uses, which violates federal regulations. This led to a congressional inquiry from the House Committee on Oversight and Government Reform in March 2007.
Last year, AstraZeneca generated sales of over $4 billion with Seroquel, and estimates suggest that more than half were for off-label use.
While AstraZeneca’s exclusive patent for the original formula is set to expire in 2011, the approval of the new extended release version will carry patent protection until 2017. Financial analysts have indicated they expect AstraZeneca to push doctors to transfer their patients to the new version
SEROQUEL ATTORNEYS
The Seroquel attorneys at Saiontz & Kirk, P.A. continue to receive inquiries from individuals who suffered serious injuries which were caused by AstraZeneca’s continued failure to properly warn about Seroquel side effects and their decisions to place profits before the safety and health of consumers.
If you, a friend or family member have been diagnosed with diabetes or pancreatitis after taking Seroquel, request a free consultation and claim evaluation.
